Skip to content
DataLookout
Menu

CARSNCT05486234

CARS: Cannabis and Alcohol Reduction Study

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 10 versions: 9 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 4 words Show 5 more changesShow less
    • Trial completed
    • Final enrollment: 46 participants (planned 52)
    • Primary completion date changed from estimate of Sep 30, 2026 to Apr 24, 2026
    • Study completion date changed from estimate of Oct 1, 2026 to Sep 30, 2026
    • Site details revised
  2. Minor Primary completion pushed from Jul 31, 2026 to Sep 30, 2026
    • Study completion pushed from Aug 1, 2026 to Oct 1, 2026
    v8
  3. Minor Primary completion date: Mar 31, 2026 to Jul 31, 2026
    • Study completion date: Jul 2026 to Aug 1, 2026
    v7
  4. Minor Primary completion date: Dec 15, 2025 to Mar 31, 2026
    • Study completion date: Mar 2026 to Jul 2026
    v6
  5. Minor Primary completion date: Aug 2025 to Dec 15, 2025v5
Show 3 earlier versionsHide 3 earlier versions
  1. Notable Eligibility criteria shortened, about 7 wordsv4
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 2023 to Jan 25, 2023
    v3
  3. Notable Start date: Aug 2022 to Jan 2023v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Change in cannabis use as assessed by Timeline Followback
Timeframe: Baseline and Three-Month Follow-up
Change in alcohol use as assessed by Timeline Followback
Timeframe: Baseline and Three-Month Follow-up
Change in Cannabis Approach Bias (D-Score)
Timeframe: Baseline, One-Week Follow-up, and Three-Month Follow-up
Change Cannabis Approach Bias (D-Score)
Timeframe: Baseline, One-Week Follow-up, and Three-Month Follow-up

Arms and interventions

Group A: Treatment GroupExperimental
Group B: Control GroupSham comparator

Behavioral: modified Approach-Avoidance Task (mAAT), which aims to modify automatic approach bias, modified Approach-Avoidance Task (mAAT) that does not aim to modify automatic approach bias.

Sites

1 site in 1 country

  • Medical University of South CarolinaCharleston, South Carolina, United States